Manufacturing and Production

Showing 15 posts of 5860 posts found.

Lonza cleared to acquire Capsugel in $5.5 billion deal

June 28, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition

Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …
kress

Biogen appoint new Head of Global Therapeutic Operations

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Jean-Paul Kress

Biogen announced that Jean-Paul Kress has been appointed to the position of Executive Vice President and President, International, and Head …
novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …
filing_cabinet

Number of patients at risk from NHS mail mistake revealed

June 27, 2017 Manufacturing and Production, Medical Communications Department of Health, Jeremy Hunt, NHS, NHS England

According to the patient records that have been examined so far, at least 1,700 may have been put at risk …
thumbs_up

Duchenne drug made available to UK patients early

June 27, 2017 Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Raxone

UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy (DMD) drug, Raxone (idebenone), through the Early Access …
pills-384846_960_720

Therapy able to block both opioid high and withdrawal

June 26, 2017 Manufacturing and Production, Research and Development Camurus, buprenorphine

A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to …
shutterstock_57369385

Drug Combinations and Emerging Interactions

June 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug combinations, drug resistance, feature

Pamela Yeh, Assistant Professor at the Department of Ecology and Evolutionary Biology, University of California, Los Angeles, discusses how drug …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …
fda2outsideweb

FDA locks down import from 3 Indian IPCA facilities

June 21, 2017 Manufacturing and Production, Research and Development FDA, India, Ipca

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …

Novartis receives positive news in eye drug P3 studies

June 20, 2017 Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …
gsk_boronia_australia

GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit

June 20, 2017 Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …
blood-1813410_960_720

‘Vaccine’ to lower cholesterol enters human trials

June 20, 2017 Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …

Pfizer launches vaccine study in Group B Streptococcus

June 20, 2017 Manufacturing and Production, Research and Development Group B Streptococcus, Pfizer

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …
The Gateway to Local Adoption Series

Latest content